Anxiety in Argentinian patients with multiple sclerosis: Prevalence and associated factors

被引:9
作者
Chertcoff, Anibal [1 ]
Curbelo, Maria Celeste [1 ]
Bauer, Johana [2 ]
Ferrandina, Flavia [2 ]
Martinez, Alejandra [1 ]
Steinberg, Judith [1 ]
Carra, Adriana [1 ,2 ]
机构
[1] Hosp Britan Buenos Aires, MS & Demyelinating Dis, Perdriel 74, RA-1280 Buenos Aires, DF, Argentina
[2] Esclerosis Multiple Argentina EMA, Uriarte 1465, RA-1414 Buenos Aires, DF, Argentina
关键词
Anxiety; Comorbidity; Latin america; Depression; Quality of life; DEPRESSION; COMORBIDITY; SYSTEM;
D O I
10.1016/j.msard.2020.102042
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: There is scarce information in Latin America regarding the prevalence of anxiety in patients with multiple sclerosis (MS) and its association with different clinical -demographic factors. Objective: We aimed to determine the prevalence of anxiety in Argentinian MS patients and to analyze associated factors. Materials and methods: A cross-sectional analysis was performed with consecutive MS outpatients from two centers in Buenos Aires, Argentina. Anxiety was evaluated according to the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A). Results: Eighty-three patients were included. Fifty-three (63%) were females, mean age: 46 (SD=13.9) years. Forty-five percent ( n = 38) had anxiety according to the HADS-A. Patients with anxiety were significantly younger (42.2 vs 49.1 years, p = 0.02), had a shorter time since diagnosis (8.3 vs 12.3 years, p = 0.02), had a history of psychiatric disorders (36.8% vs 8.8%, p = 0.002), were depressed (57.8% vs 2.2%, p <0.001) and had worse health -related quality of life according to the COOP/Wonca questionnaire (mean score: 21.5 vs 15.2, p <0.001). Depression (OR: 15.2, 95% CI 1.4-157.3, p = 0.02) and worse health -related quality of life (OR: 1.2,95% CI 1-1.4, p = 0.008) remained significantly associated with anxiety after adjusting for all other sig- nificant variables. No differences were observed regarding sex, marital and occupational status, education, fa- mily history of psychiatric disorders, disease course and disability according to the EDSS. Conclusions: The prevalence of anxiety in Argentinian MS outpatients was higher than previously reported in other populations. Anxiety was strongly associated with negative outcomes such as depression and reduced health -related quality of life. These results emphasize the burden of psychiatric morbidity in Argentinian MS patients.
引用
收藏
页数:5
相关论文
共 30 条
[21]   Validity of four screening scales for major depression in MS [J].
Patten, Scott B. ;
Burton, Jodie M. ;
Fiest, Kirsten M. ;
Wiebe, Samuel ;
Bulloch, Andrew G. M. ;
Koch, Marcus ;
Dobson, Keith S. ;
Metz, Luanne M. ;
Maxwell, Colleen J. ;
Jette, Nathalie .
MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (08) :1064-1071
[22]  
SkromneEisenberg E., 2017, MULT SCLER J EXP TRA, V25
[23]  
Stagnaro Juan C, 2018, Vertex, VXXIX, P275
[24]  
Tauil CB, 2018, ARQ NEURO-PSIQUIAT, V76, P296, DOI [10.1590/0004-282X20180036, 10.1590/0004-282x20180036]
[25]   Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria [J].
Thompson, Alan J. ;
Banwell, Brenda L. ;
Barkhof, Frederik ;
Carroll, William M. ;
Coetzee, Timothy ;
Comi, Giancarlo ;
Correale, Jorge ;
Fazekas, Franz ;
Filippi, Massimo ;
Freedman, Mark S. ;
Fujihara, Kazuo ;
Galetta, Steven L. ;
Hartung, Hans Peter ;
Kappos, Ludwig ;
Lublin, Fred D. ;
Marrie, Ruth Ann ;
Miller, Aaron E. ;
Miller, David H. ;
Montalban, Xavier ;
Mowry, Ellen M. ;
Sorensen, Per Soelberg ;
Tintore, Mar ;
Traboulsee, Anthony L. ;
Trojano, Maria ;
Uitdehaag, Bernard M. J. ;
Vukusic, Sandra ;
Waubant, Emmanuelle ;
Weinshenker, Brian G. ;
Reingold, Stephen C. ;
Cohen, Jeffrey A. .
LANCET NEUROLOGY, 2018, 17 (02) :162-173
[26]   Disease-modifying treatments for multiple sclerosis - a review of approved medications [J].
Torkildsen, O. ;
Myhr, K. -M. ;
Bo, L. .
EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 :18-27
[27]   The prevalence of anxiety and associated factors in persons with multiple sclerosis [J].
Tram Pham ;
Jette, Nathalie ;
Bulloch, Andrew G. M. ;
Burton, Jodie M. ;
Wiebe, Samuel ;
Patten, Scott B. .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 19 :35-39
[28]   Anxiety in multiple sclerosis is related to depressive symptoms and cognitive complaints [J].
Wallis, Olga ;
Bol, Yvonne ;
Kohler, Sebastian ;
van Heugten, Caroline .
ACTA NEUROLOGICA SCANDINAVICA, 2020, 141 (03) :212-218
[29]   Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis [J].
Wood, B. ;
van der Mei, I. A. F. ;
Ponsonby, A-L ;
Pittas, F. ;
Quinn, S. ;
Dwyer, T. ;
Lucas, R. M. ;
Taylor, B. V. .
MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (02) :217-224
[30]   Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis [J].
Zhang, Tingting ;
Tremlett, Helen ;
Leung, Stella ;
Zhu, Feng ;
Kingwell, Elaine ;
Fisk, John D. ;
Bhan, Virender ;
Campbell, Trudy L. ;
Stadnyk, Karen ;
Yu, B. Nancy ;
Marrie, Ruth Ann .
NEUROLOGY, 2016, 86 (14) :1287-1295